Trial Details
COMPLETEDBasic Information
| Clinical ID | c1387 |
|---|---|
| Identifier | NCT06080048 |
| Trial Title | A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: SOR102|DRUG: Placebo |
Participant Information
| Sponsor | Sorriso Pharmaceuticals, Inc. |
|---|---|
| City | Tbilisi |
| Country/Region | Georgia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-10-24 |
|---|---|
| Primary Completion Date | 2024-10-16 |
| Completion Date | 2024-11-08 |